GeneTrait Pain Management Panel

GeneTrait’s Pain Management panel evaluates genetic markers responsible for metabolism of many common pain management medications including opiates, NSAIDs, methotrexate, and tricyclic antidepressants, plus elevated risk of hyperhomocysteinemia.

NUMBER OF INDIVIDUAL GENES TESTED:

  • 8

MEDICATION CATEGORIES:

  • Methotrexate
  • Opiate
  • NSAID
  • Tricyclic Antidepressants

RISK FACTORS EVALUATED:

  • Hyperhomocysteinemia